Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 30:19:1584555.
doi: 10.3389/fnins.2025.1584555. eCollection 2025.

In vitro electrophysiological characterization of Parkinson's disease: challenges, advances, and future directions

Affiliations
Review

In vitro electrophysiological characterization of Parkinson's disease: challenges, advances, and future directions

Sara Grasselli et al. Front Neurosci. .

Abstract

Parkinson's disease is the second most common neurodegenerative disorder, characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the accumulation of α-synuclein aggregates. While significant progress has been made in understanding the genetic and biological aspects of Parkinson's disease, its complex pathophysiology remains poorly understood, and current therapeutic approaches are largely symptomatic. Advanced in vitro models have emerged as essential tools for studying Parkinson's disease related mechanisms and developing new therapeutic strategies. However, the electrophysiological characterization of neurons in these models remains underexplored. This review highlights the importance of employing electrophysiological techniques, such as patch-clamp recordings and microelectrode arrays, in providing critical insights into neuronal dysfunction, synaptic impairments, and network disruptions in Parkinson's disease. The aim is to summarize the key discoveries in the electrophysiological characterization of the pathology and the related progress made in recent years, underlying the main challenges, including the lack of standardized protocols, and the heterogeneity of cellular sources and culture systems. Addressing these limitations is crucial for improving reproducibility and facilitating cross-study comparisons, allowing for a deeper understanding of Parkinson's disease pathophysiology. By refining and standardizing electrophysiological approaches, these efforts will enhance our understanding of Parkinson's disease's underlying mechanisms, ultimately accelerating the discovery of robust biomarkers and the development of more effective therapeutic strategies.

Keywords: Parkinson’s disease; electrophysiology; in vitro models; microelectrode arrays; patch-clamp.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Schematical representation of Parkinson’s disease characterization leveraging in vitro electrophysiological techniques: from intracellular recordings using patch-clamp (a) to extracellular recordings using MEAs (b).

Similar articles

Cited by

References

    1. Abdelrahman S., Alsanie W. F., Khan Z. N., Albalawi H. I., Felimban R. I., Moretti M., et al. . (2022). A Parkinson’s disease model composed of 3D bioprinted dopaminergic neurons within a biomimetic peptide scaffold. Biofabrication 14:044103. doi: 10.1088/1758-5090/ac7eec, PMID: - DOI - PubMed
    1. Abdullah R., Basak I., Patil K. S., Alves G., Larsen J. P., Møller S. G. (2015). Parkinson’s disease and age: the obvious but largely unexplored link. Exp. Gerontol. 68, 33–38. doi: 10.1016/j.exger.2014.09.014, PMID: - DOI - PubMed
    1. Amin H., Nieus T., Lonardoni D., Maccione A., Berdondini L. (2017). High-resolution bioelectrical imaging of Aβ-induced network dysfunction on CMOS-MEAs for neurotoxicity and rescue studies. Sci. Rep. 7:2460. doi: 10.1038/s41598-017-02635-x, PMID: - DOI - PMC - PubMed
    1. Angela Cenci M. (2014). Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, the therapeutic implications. Front. Neurol. 5:73–87. doi: 10.3389/fneur.2014.00242, PMID: - DOI - PMC - PubMed
    1. Armstrong M. J., Okun M. S. (2020). Diagnosis and treatment of Parkinson disease: a review. JAMA - J. American Medical Association 323, 548–560. doi: 10.1001/jama.2019.22360 - DOI - PubMed

LinkOut - more resources